$0.65
3.83% yesterday
Nasdaq, Jun 27, 10:03 pm CET
ISIN
US8964383066
Symbol
TRIB

Trinity Biotech Plc Sponsored ADR Class A Stock price

$0.65
-0.02 2.90% 1M
-0.15 18.69% 6M
-0.23 25.93% YTD
-1.43 68.65% 1Y
-6.13 90.39% 3Y
-11.60 94.68% 5Y
-89.45 99.28% 10Y
-32.60 98.04% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.03 3.83%
ISIN
US8964383066
Symbol
TRIB
Sector

Key metrics

Basic
Market capitalization
$12.6m
Enterprise Value
$108.2m
Net debt
$95.6m
Cash
$5.2m
Shares outstanding
30.6m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.20 | 0.18
EV/Sales
1.76 | 1.55
EV/FCF
negative
P/B
negative
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.00% | 0.00%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.00% | 0.00%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$61.6m | $69.9m
EBITDA
$-16.0m | -
EBIT
$-17.9m
Net Income
$-31.8m | $-28.1m
Free Cash Flow
$-14.3m
Growth (TTM | estimate)
Revenue
8.32% | 13.50%
EBITDA
-13.14% | -
EBIT
-12.20%
Net Income
-32.35% | 11.73%
Free Cash Flow
0.00%
Margin (TTM | estimate)
Gross
34.83%
EBITDA
-26.03% | -
EBIT
-29.05%
Net
-51.64% | -40.16%
Free Cash Flow
-23.16%
Financial Health
Equity Ratio
-34.06%
Return on Equity
90.36%
ROCE
-25.12%
ROIC
-26.51%
Debt/Equity
-2.86
More
EPS
$-0.09
FCF per Share
$-0.47
Short interest
0.44%
Employees
380.00
Rev per Employee
$160.00k
Show more

Is Trinity Biotech Plc Sponsored ADR Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Trinity Biotech Plc Sponsored ADR Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Trinity Biotech Plc Sponsored ADR Class A forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Trinity Biotech Plc Sponsored ADR Class A forecast:

Buy
86%
Hold
14%

Financial data from Trinity Biotech Plc Sponsored ADR Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
62 62
8% 8%
100%
- Direct Costs 40 40
7% 7%
65%
21 21
10% 10%
35%
- Selling and Administrative Expenses 33 33
6% 6%
54%
- Research and Development Expense 4.54 4.54
4% 4%
7%
-16 -16
13% 13%
-26%
- Depreciation and Amortization 1.87 1.87
5% 5%
3%
EBIT (Operating Income) EBIT -18 -18
12% 12%
-29%
Net Profit -32 -32
32% 32%
-52%

In millions USD.

Don't miss a Thing! We will send you all news about Trinity Biotech Plc Sponsored ADR Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Trinity Biotech Plc Sponsored ADR Class A Stock News

Neutral
GlobeNewsWire
4 days ago
Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability
Neutral
GlobeNewsWire
about one month ago
DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2024 and the fiscal year then ended.
Neutral
GlobeNewsWire
4 months ago
DUBLIN, March 14, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice today from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5450(a)(1), requiring that listed securities maintain...
More Trinity Biotech Plc Sponsored ADR Class A News

Company Profile

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Head office Ireland
CEO John Gillard
Employees 380
Founded 1992
Website www.trinitybiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today